Even as Johnson & Johnson is settling previous charges that may cost about $2.2 billion, the government is making new inquiries into allegations that the company used illegal tactics to promote and market its drugs, the Wall Street Journal reports.
According to the Wall Street Journal, the U.S. Justice Department sent J&J’s Janssen Pharmaceuticals unit a letter in April, requesting documents related to the marketing and promotion of the antibiotic Doribax.
In ...
continue reading...
The investment blog Seeking Alpha says Johnson & Johnson is doing quite well financially despite its recent problems – including high-profile and costly recalls of faulty medical devices.
The report notes that Warren Buffett’s Berkshire Hathaway Inc. dropped two-thirds of its holdings in the company, following a $1.1 billion fine from an Arkansas jury that ruled the firm misled doctors and patients about the risks of antipsychotic medication Risperdal.
Johnson & Johnson ...
continue reading...
Johnson & Johnson will pay 36 states and the District of Columbia $181 million as a settlement for allegations that the company inappropriately marketed its antipsychotic drug Risperdal, the Philadelphia Inquirer reports.
Federal and state investigators have been examining the company’s Risperdal marketing practices for almost a decade, according to the Inquirer. The $181 million agreement is separate from a continuing federal investigation that could lead to criminal charges against Johnson ...
continue reading...
Two studies suggest that removing blood clots from the brain with small nets could improve recovery for stroke victims, according to a BBC report.
The report is based on two studies presented in the Lancet medical journal. The clot retrieval devices are intended to be an alternative to “clot-busting” drugs, which need to be administered hours after a stroke and are not suitable for all patients.
And some medical devices currently ...
continue reading...
Ramon Rossi Lopez, a partner with Lopez McHugh, has been included in the 19th edition of The Best Lawyers in America, for his work in the practice area of Mass Tort Litigation/Class Actions — Plaintiffs.
Selection for Best Lawyers is based on an exhaustive and rigorous peer-review survey involving more than 4 million confidential evaluations by the top attorneys in the country. No fee or purchase is required, which makes ...
continue reading...A column by Dr. Anthony L. Komaroff in North Carolina’s Daily Reflector cautions about the effects of drug interactions for patients taking the medication warfarin – an anticoagulant, or blood thinner.
Komaroff writes that some antibiotics and antifungal drugs increase warfarin’s ability to stop blood clotting, but others do the opposite. Some topical antibiotics that are applied directly to the skin can also interfere with warfarin. He recommends that anyone ...
continue reading...
